Acromegaly Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Amryt, Chiasma, Recordati, Novartis, Sun Pharma, Crinetics Pharmaceuticals, Camurus, Ionis Pharmaceuticals

In 2021, the Acromegaly Market size was USD 1,326.6 million, which is expected to rise during the study period (2019-2032). As per DelveInsight, the Acromegaly Market is anticipated to evolve immensely in the coming years owing to the increasing prevalence of acromegaly, incentives of orphan drug designation, and intense development of efficacious mono and combination therapies.

DelveInsight's "Acromegaly Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Acromegaly Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Acromegaly therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Acromegaly treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Acromegaly: An Overview
Acromegaly is a rare disorder caused by excessive growth hormone production (GH), most commonly from an adenoma of the anterior pituitary gland. is usually a slow-progressing disorder, with onset usually in the third or fourth decade of life.

Acromegaly is most commonly caused by a somatotroph GH-secreting adenoma of the anterior pituitary gland. The most commonly associated mutation involves activating the alpha subunit of the guanine nucleotide stimulatory protein gene. Other causes of primary GH excess include pituitary adenomas that secrete multiple hormones and GH-cell carcinomas. Rarer causes of acromegaly are related to GHRH excess. These can be further divided into central and peripheral causes. Central causes include hypothalamic hamartomas, choristoma, and ganglioneuroma. Peripheral causes include secretion of GHRH by bronchial carcinoid tumors, small cell lung cancer, adrenal adenoma, and other

Acromegaly treatment options include surgery, medicines, and radiation therapy. The goals of treatment are to control tumor size, return GH and IGF-I levels to normal, improve symptoms, and manage related health problems. Currently, three types of medicines are used to treat acromegaly, but they are not a cure. The medicines may be used alone or in combination with each other. Somatostatin analogs, Dopamine agonists, and Growth hormone-receptor antagonists are the currently available medicines. The third treatment option is radiation therapy (Stereotactic and Conventional), which uses high-energy X-rays or particle waves to kill tumor cells.

Acromegaly Market Key Facts
• In the year 2021, the total diagnosed prevalent cases of Acromegaly was 57,824 cases in the 7MM which is expected to grow during the study period, i.e., 2019-2032.
• The total Acromegaly market size in the United States accounted for USD 719.1 million in 2021.
• In EU5, the total Acromegaly market size was USD 423.2 million in 2021.
• In Japan, the total Acromegaly market size was USD 184.3 million in 2021.
• As per the DelveInsight estimates, in the year 2021, the total diagnosed prevalent cases of Acromegaly were ~57,500 cases in the 7MM.
• According to the Matsubayashi and Kawakami (2020), the average annual prevalence of acromegaly for persons aged ≥20 years in Japan was 9.2 per 100,000.
• As per the study by Crisafulli et al. (2021), acromegaly is a rare condition, in line with the EU definition as a disease affecting no more than 5 per 10,000 people.
• According to the study by Oliveira et al. (2021), acromegaly is a chronic debilitating disorder with a reported prevalence of up to 13.7 per 100,000 people. Most patients with acromegaly are diagnosed between 18 and 64 years of age, with a peak during the fourth decade of life, coinciding with their most productive working years.

Discover How Acromegaly Market Will Grow by 2032:
https://www.delveinsight.com/report-store/acromegaly-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acromegaly Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Acromegaly therapies in the market. It also provides a detailed assessment of the Acromegaly market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Acromegaly drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Acromegaly Epidemiology
The epidemiology section covers detailed insights into the historical, and current Acromegaly patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Acromegaly Epidemiology Segmented as -
• Total Diagnosed prevalent Cases of Acromegaly in the 7MM (2019-2032)
• Total Treated Cases of Acromegaly in the 7MM (2019-2032)
• Total Tumor size Cases of Acromegaly in the 7MM (2019-2032)
• Total Tumor origin-specific Cases of Acromegaly in the 7MM (2019-2032)
• Total Gender-specific Cases of Acromegaly in the 7MM (2019-2032)

Get Key Insights Into the Evolving Acromegaly Epidemiology Trends:
https://www.delveinsight.com/report-store/acromegaly-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acromegaly Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acromegaly market or expected to be launched during the study period. The analysis covers the market share by Acromegaly drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Acromegaly Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acromegaly Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Acromegaly. Currently, Crinetics Pharmaceuticals is leading the therapeutics market with its Acromegaly drug candidates in the most advanced stage of clinical development.

Leading Companies in the Acromegaly Therapeutics Market Include
• Amryt
• Chiasma
• Recordati
• Novartis Pharmaceuticals
• Sun Pharma
• Crinetics Pharmaceuticals
• Camurus
• Ionis Pharmaceuticals
And Many Others

Emerging and Marketed Acromegaly Therapies Covered in the Report Include
• IONIS-GHR-LRX: Ionis Pharmaceuticals
• Paltusotine: Crinetics Pharmaceuticals
And Many More

Learn More About the Emerging Therapies & Key Companies in the Acromegaly Therapeutics Market:
https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Acromegaly Competitive Intelligence Analysis
4. Acromegaly Market Overview at a Glance
5. Acromegaly Background and Overview
6. Acromegaly Patient Journey
7. Acromegaly Epidemiology and Patient Population
8. Acromegaly Treatment Algorithm, Current Treatment, and Medical Practices
9. Acromegaly Unmet Needs
10. Key Endpoints of Acromegaly Treatment
11. Acromegaly Marketed Products
12. Acromegaly Emerging Therapies
13. Acromegaly Seven Major Market Analysis
14. Attribute Analysis
15. Acromegaly Market Outlook (7 major markets)
16. Acromegaly Access and Reimbursement Overview
17. KOL Views on the Acromegaly Market.
18. Acromegaly Market Drivers
19. Acromegaly Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market

Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market

Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market

Diabetes Market
https://www.delveinsight.com/report-store/diabetes-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market

Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market

Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market

Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market

Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market

Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market

India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report

Insulin Glargine Biosimilar Insight
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market

Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.